Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 38881 - 38900 out of 558245 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L01FX28) glofitamab | Columvi 10 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 10 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | RocheProductsPtyLtd |
| Australia | (L01FX28) glofitamab | Columvi 2.5 mg/2.5 mL injection, 2.5 mL vial | Solution concentrate for I.V. infusion 2.5 mg in 2.5 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | RocheProductsPtyLtd |
| Australia | (L01FX28) glofitamab | Columvi 2.5 mg/2.5 mL injection, 2.5 mL vial | Solution concentrate for I.V. infusion 2.5 mg in 2.5 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | RocheProductsPtyLtd |
| Australia | (L01FX28) glofitamab | Columvi 2.5 mg/2.5 mL injection, 2.5 mL vial | Solution concentrate for I.V. infusion 2.5 mg in 2.5 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Large B-Cell, Diffuse | RocheProductsPtyLtd |
| Australia | (L01FX32) elranatamab | Elrexfio 44 mg/1.1 mL injection, 1.1 mL vial | Solution for subcutaneous injection 44 mg in 1.1 mL (40 mg per mL), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | PfizerAustraliaPtyLtd |
| Australia | (L01FX32) elranatamab | Elrexfio 44 mg/1.1 mL injection, 1.1 mL vial | Solution for subcutaneous injection 44 mg in 1.1 mL (40 mg per mL), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | PfizerAustraliaPtyLtd |
| Australia | (L01FX32) elranatamab | Elrexfio 44 mg/1.1 mL injection, 1.1 mL vial | Solution for subcutaneous injection 44 mg in 1.1 mL (40 mg per mL), 1 pcs | Wholesale price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | PfizerAustraliaPtyLtd |
| Australia | (L01FX32) elranatamab | Elrexfio 44 mg/1.1 mL injection, 1.1 mL vial | Solution for subcutaneous injection 44 mg in 1.1 mL (40 mg per mL), 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | PfizerAustraliaPtyLtd |
| Australia | (L01FX32) elranatamab | Elrexfio 76 mg/1.9 mL injection, 1.9 mL vial | Solution for subcutaneous injection 76 mg in 1.9 mL (40 mg per mL), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | PfizerAustraliaPtyLtd |
| Australia | (L01FX32) elranatamab | Elrexfio 76 mg/1.9 mL injection, 1.9 mL vial | Solution for subcutaneous injection 76 mg in 1.9 mL (40 mg per mL), 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | PfizerAustraliaPtyLtd |
| Australia | (L01FX32) elranatamab | Elrexfio 76 mg/1.9 mL injection, 1.9 mL vial | Solution for subcutaneous injection 76 mg in 1.9 mL (40 mg per mL), 1 pcs | Wholesale price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | PfizerAustraliaPtyLtd |
| Australia | (L01FX32) elranatamab | Elrexfio 76 mg/1.9 mL injection, 1.9 mL vial | Solution for subcutaneous injection 76 mg in 1.9 mL (40 mg per mL), 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | PfizerAustraliaPtyLtd |
| Australia | (L01FY02) nivolumab and relatlimab | Opdualag injection, 20 mL vial | Solution concentrate for I.V. infusion containing 240 mg nivolumab and 80 mg relatlimab in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FY02) nivolumab and relatlimab | Opdualag injection, 20 mL vial | Solution concentrate for I.V. infusion containing 240 mg nivolumab and 80 mg relatlimab in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FY02) nivolumab and relatlimab | Opdualag injection, 20 mL vial | Solution concentrate for I.V. infusion containing 240 mg nivolumab and 80 mg relatlimab in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FY02) nivolumab and relatlimab | Opdualag injection, 20 mL vial | Solution concentrate for I.V. infusion containing 240 mg nivolumab and 80 mg relatlimab in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FY02) nivolumab and relatlimab | Opdualag injection, 20 mL vial | Solution concentrate for I.V. infusion containing 240 mg nivolumab and 80 mg relatlimab in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FY02) nivolumab and relatlimab | Opdualag injection, 20 mL vial | Solution concentrate for I.V. infusion containing 240 mg nivolumab and 80 mg relatlimab in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01XA01) cisplatin | Cisplatin (Accord) 100 mg/100 mL injection, 100 mL vial | I.V. injection 100 mg in 100 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | AccordHealthcarePty.Ltd. |
| Australia | (L01XA01) cisplatin | Cisplatin (Accord) 100 mg/100 mL injection, 100 mL vial | I.V. injection 100 mg in 100 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | AccordHealthcarePty.Ltd. |
Pages
